Anthrogen
This role involves owning in-vivo research for designed biological systems, from selecting appropriate models to interpreting exposure, activity, and tolerability. The scientist will design and execute studies, connect exposure and tissue distribution to target engagement, and investigate differences between in-vitro and in-vivo behavior. The position requires a hands-on approach to scientific inquiry and collaboration with platform and ML researchers to inform design decisions.
Generate molecular machines for human health, frontier manufacturing, and broader society.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Anthrogen.
Research Scientist, in vivo Pharmacology-Oncology
Novartis
Scientist III (In Vivo Studies)
Exelixis
Principal Scientist - In Vivo Pharmacology
State of Indiana
Ophthalmology Discovery Research Team Member
Merck & Co., Inc.
Senior Director, In Vivo Pharmacology
Generate:Biomedicines
Discovery Scientists, in vitro and in vivo Pharmacology, in Cardiovascular & Metabolic Disease Research
Roche